Skip to Content

SalvaRx Group PLC

Rating as of

Company Profile

Business Description

SalvaRx Group PLC is engaged in drug discovery and development, focused on immune oncology. The company invests in novel cancer immuno-therapies and provides its portfolio companies with operational support ranging from direct operation of subsidiaries to advisory or part-time involvement in more established companies. It expects the study to evaluate approximately three treatment groups: a control arm using the standard of care (an anti-programmed death (PD)-1 therapy), a trial arm using iOX Therapeutics Ltd's drug (IMM60), and a third arm that will test the combination of IMM60 and an anti-PD1 therapy.

1 Bowring Road, Commerce House
Ramsey, IM8 2LQ, Isle Of Man
T +44 1624811611
Sector Healthcare
Industry Biotechnology
Most Recent Earnings
Fiscal Year End Dec 31, 2019
Stock Type
Employees 4